Showing results (91-100 of 154) with videos related to
Sort By:
Pageof 16
Biorxiv : the Preprint Server for Biology|January 18, 2024
PDGFRα/β heterodimer activation negatively affects downstream ERK1/2 signaling and cellular proliferationMaria B Campaña, Madison R Perkins, Maxwell C McCabe, et al.Journal of the International Neuropsychological Society : JINS|January 31, 2004
Working memory and processing speed deficits in systemic lupus erythematosus as measured by the paced auditory serial addition testJanet L Shucard, Joy Parrish, David W Shucard, et al.Biorxiv : the Preprint Server for Biology|July 3, 2026
Particle-Only gECM Wafers Enable Cohesive, ECM-Rich Scaffolds Without Secondary PolymersShannon A Blanco, Juliet O Heye, Stephanie E Schneider, et al.Circulation|August 1, 1981
Complications of percutaneous intraaortic balloon pumpingJ C Harvey, J E Goldstein, J C McCabe, et al.Plant Physiology|October 11, 2003
Analysis of the alternative oxidase promoters from soybeanDavid Thirkettle-Watts, Tulene C McCabe, Rachel Clifton, et al.Health Technology Assessment (Winchester, England)|February 5, 2011
A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's diseaseJ Dretzke, R Edlin, J Round, et al.International Journal of Molecular Sciences|November 27, 2025
Unraveling the Matrix: Proteomic Profiling Reveals Stromal ECM Dysregulation in Severe Early-Onset Fetal Growth RestrictionStefano Ginocchio, Maxwell C McCabe, Amanda R Flockton, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
Proteomic analysis reveals regional sex differences in healthy and fibrotic human lungRachel Blomberg, Jeremy A Herrera, Haley Noelle, et al.The Journal of Extra-Corporeal Technology|June 19, 2026
Comparative decision-making analysis of extracorporeal membrane oxygenation candidacy based on a survey of pediatric critical care fellow and attending physicians☆Ish Sethi, Brenna C McCabe, Ryan W Morgan, et al.Health Technology Assessment (Winchester, England)|November 5, 2010
Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumoursJ Dretzke, J Round, M Connock, et al.Pageof 16